DR. SHEREBANU F GASLIGHTWALA MD
Prescription History 1790718708
Obstetrics & Gynecology in Kansas City, KS

Active since July 10, 2006PECOS EnrolledAccepts Medicare Assignment
9501 STATE AVE, SUITE #3, KANSAS CITY, KS 66111(913) 299-2229(913) 334-0664 Get Directions

NPPES record last updated: July 8, 2007. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SHEREBANU F GASLIGHTWALA MD, an active Obstetrics & Gynecology specialist practicing in Kansas City, KS. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 12 documented patient claims. Among these therapy options, the most frequently utilized medication is Premarin, which accounts for 12 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
12
Total Claims
23
30-Day Fills
Premarin
Most Prescribed · 12 claims
View details
1 medication · 2023 Medicare Part D
Medicare Part D medications prescribed by DR. SHEREBANU F GASLIGHTWALA MD in 2023, with prescription volumes, average cost per fill, and KS state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other KS PrescribersVs. KS Avg
PremarinEstrogens, Conjugated12$474.75 Typical

About Premarin: This medication is a female hormone. Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. Certain estrogen products may also be used by men and women to treat cancers (certain types of prostate cancer, breast cancer that has spread to other parts of the body) and by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.

In 2023, this provider wrote 12 Medicare prescriptions for Premarin, about 75% of the volume of the typical Kansas prescriber of this medication (16). Medicare paid an average of $474.75 per fill, versus $326.97 statewide.

How often this provider prescribes it

This provider
12
KS average
16.0

This provider's prescribing volume for this medication is in line with the average KS prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$474.75
KS average
$326.97

Gross Part D cost per fill; not the patient's out-of-pocket price.

23.3
30-Day Fills
standardized to 30-day supplies
700
Days of Medication
total across all patients in 2023
No medications match the current filters.
More than typical Typical Less than typical= prescription volume vs the average KS prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the KS average cost per fill.

About this data. The prescription history for DR. SHEREBANU F GASLIGHTWALA MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this Kansas City, KS practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among KS prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.